Summary. The antifertility effects of two non-steroidal compounds, clomiphene and a diphenylindene derivative (U-11555A), were studied in the mouse, using two different methods. First, the effects of various concentrations of the compounds on the in-vitro development of two-cell mouse embryos into blastocysts were investigated. Second, the oral doses of the compounds which were necessary to block pregnancy in mice were determined. It was found that the inhibitory doses for mice are somewhat higher than for rats. Although it is impossible to make direct comparisons between the effective in-vivo and in-vitro doses, the inhibitory concentrations seem to be of nearly the same order in both cases.
INTRODUCTION
The use of certain non-steroidal compounds as oral antifertility agents in animals has been the subject of several recent investigations. The compounds include a group synthesized by the Merrell Company (MER-25 and clomi¬ phene, MRL-41) and a group produced by the Upjohn Company (U-l 1555A, U-10520A and U-11100A). Most of the investigations have involved the antifertility effects of injected or oral doses during the first few days of pregnancy in the rat (Barnes & Meyer, 1962; Davidson, Schuckner & Wada, 1965; Duncan, Stucki, Lyster & Lednicer, 1962; Nelson, Davidson & Wada, 1963; Segal & Nelson, 1961) . During this period the zygotes are undergoing cleavage and blastocyst formation, while being transported through the oviduct to the uterus, in preparation for implantation. At present, there is disagreement among investigators as to whether these compounds act directly on the embryo, affect the rate of tubai transport or interfere with implantation.
The present study involves two of the compounds mentioned above : clomi¬ phene, which is a triphenylethylene derivative, and U-l 1555A, which is a diphenylindene derivative. The purpose of the investigation was two-fold: Joan L. Thomson first, to determine the effects of various single and multiple oral doses of the two compounds on pregnancy in the mouse, and to compare these with the effects on other species; and second, to compare the doses required to block pregnancy in vivo with the doses which prevent the in-vitro development of two-cell embryos into blastocysts.
MATERIALS AND METHODS
Determination of dose response in vitro Two-cell embryos were obtained from superovulated random-bred Swiss adult mice. The animals were given 10 i.u. pregnant mare serum gonadotrophin (Gestyl, Organon) intraperitoneally, followed 48 hr later by the injection of 10 i.u. human chorionic gonadotrophin (Pregnyl, Organon) . After the second injection females were placed with males and were checked the next morning for vaginal copulation plugs. Twenty-four hours later the oviducts were aseptically removed from the pregnant mice, and the two-cell embryos were collected by flushing the tubes with culture medium (Brinster, 1963 (Brinster, , 1965 (Biggers & Brinster, 1965 (P<0-01) than those of the high and middle dose groups, while there were no significant differences between the control groups and the groups receiving the lowest doses.
In studying the effect of the two compounds on the number of implantation sites per pregnant mouse, the large amount of variation involved makes it difficult to evaluate the significance of the data (Table 5 ). In general, the data suggest that increasing the dose of either compound causes a decrease in the number of implanting embryos per pregnant mouse.
DISCUSSION
The culture experiments have shown that fairly low concentrations of both antifertility agents interfere with the in-vitro development of pre-implantation The gavaging experiments indicated that the doses of the two agents which completely block pregnancy in mice are somewhat higher than those effective for rats. In rats, the doses of clomiphene which prevent pregnancy are 0-3 mg/kg/day for Days 1 to 4 or 0-9 mg/kg/day on any one of the first 4 days of pregnancy (Nelson et al., 1963) . These amounts are one tenth those required to block pregnancy completely in the mouse. With U-11555A, the antifertility doses for rats are 1 mg/kg/day for the quadruple dose or 5 mg/kg for a single dose (Nelson et al., 1963) . The effective doses of this compound for the mouse are approximately four times those effective in the rat. On the other hand, the antifertility doses for rabbits appear to be comparable to those for mice (Chang, 1964) . Differences between species may represent inherent differences in susceptibility, but could also be due to variations in technical details. For example, the solvent vehicle for administration of the compounds, as well as the method of gavage, differs in studies by different investigators.
In comparing the effects of different regimens, it was found that, for clomi¬ phene, there were no significant differences between the response to single doses and to the equivalent multiple doses. With U-l 1555A, there were significantly more mice pregnant with the lowest single dose than with the corresponding quadruple dose. Since the same was true of the single-and multiple-dose control groups, however, it is likely that the lower number of pregnancies in the one multiple-dose group was due to the increased amount of handling of the pregnant mice. In general, it appears likely that the multiple doses have an accumulative effect, since the dose response curves for the single doses and the total multiple doses are quite similar. It was also found that the single dose of each compound which completely blocked pregnancy was equally effective on the 1st, 2nd, 3rd or 4th day of pregnancy (J. L. Thomson, unpublished data).
The effect of dose of the compounds on the number of implanting conceptuses suggests that increasing doses of the compounds cause a decrease in the number of implantation sites, although the large amount of variation makes it impossible to draw any definite conclusions. If this were the case, one might suspect that the compounds were causing a reduction in the viability of the embryos. A comparison of the in-vitro and in-vivo effective doses is difficult, unless one is able to determine the distribution of the in-vivo dose in the body of the mouse, and, in particular, the amounts found in the oviducal and uterine fluids. If one assumes, for purposes of discussion only, that the compounds are distributed equally to all areas of the body, the following rough comparisons can be made. For clomiphene, the effective single in-vivo dose is 9 mg/kg or 9 µg|g, as compared with the effective in-vitro concentration of 0-4 /ig/ml. A single oral dose of 20 mg/kg or 20 µg|g of U-l 1555A was completely effective in blocking pregnancy, while the lowest inhibitory in-vitro dose was 20 µg| nl. Thus it is likely that the effective in-vitro and in-vivo doses are at least in the same range of concentrations. On this basis, one cannot eliminate the possi-
